Keywords: zeffix, approved, taiwan, hepatitis, glaxo, wellcome, biochem

Zeffix approved in Taiwan for hepatitis B

Article | 02 November 1999

Glaxo Wellcome and BioChem Pharma's Zeffix (lamivudine) has beenapproved for the treatment of patients with chronic hepatitis B virus infection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Epivir

Lamivudine

Go to drug listing